COMP <GO>
SBFM vs REVB // FORWARD P/E MULTIPLE
Sunshine Biopharma Inc. (NASDAQ) VS. Revelation Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: SBFM 2
— REVB 2
■ METRIC PARITY
LAST: $2.75 (-6.14%) • MKT CAP: $2.2M
forward-pe
—
LAST: $4.05 (+0.50%) • MKT CAP: $2.3M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SBFM VS. REVB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SBFM | REVB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.40% | -35.00% | +13.60 | SBFM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -17.20% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -16.50% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 4.10% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | SBFM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.8 | 41.6 | -12.80 | REVB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.2M | $2.3M | -$63.7K | REVB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SBFM REV | REVB REV | SBFM GROSS % | REVB GROSS % | SBFM FCF | REVB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $36.3M | $25.4M | 33.8% | — | -$5.5M | -$8.3M |
| FY 2024 | $34.9M | $22.3M | 30.6% | — | -$14.2M | -$18.3M |
| FY 2023 | $24.1M | $24.2M | — | — | -$8.8M | -$7.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SBFM // BETA —
REVB // BETA —